{"date":"2025-05-28","count":44,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1789-2025-05-28-1839-cw4cbf","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"18:39:59","subject":"公告本公司董事會許可解除經理人競業禁止限制事宜","clause":"第21款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-05-28 18:39，「公告本公司董事會許可解除經理人競業禁止限制事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-05-28-1839-9od6gy","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"18:39:48","subject":"公告本公司董事會決議除息基準日暨現金股利發放日","clause":"第14款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-05-28 18:39，「公告本公司董事會決議除息基準日暨現金股利發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-05-28-1839-t453yu","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"18:39:36","subject":"公告本公司民國114年股東常會通過許可解除董事(含獨立董事)及其代表人競業禁止之限制","clause":"第21款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-05-28 18:39，「公告本公司民國114年股東常會通過許可解除董事(含獨立董事)及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-05-28-1839-1863nbk","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"18:39:25","subject":"公告本公司民國114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-05-28 18:39，「公告本公司民國114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-05-28-1812-aa9npj","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"18:12:43","subject":"本公司受邀參加第一金證券(股)公司舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-05-28 18:12，「本公司受邀參加第一金證券(股)公司舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-05-28-1723-n50p0v","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"17:23:52","subject":"公告本公司與Adalvo Limited簽署眼部術後炎症和疼痛治療新藥APP13007於歐洲及巴西市場之獨家授權合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-05-28 17:23，「公告本公司與Adalvo Limited簽署眼部術後炎症和疼痛治療新藥APP13007於歐洲及巴西市場之獨家授權合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-05-28-1722-bsfxdj","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"17:22:15","subject":"公告本公司會計主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-05-28 17:22，「公告本公司會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2025-05-28-1704-ds864w","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"17:04:59","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：生展（8279），2025-05-28 17:04，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2025-05-28-1703-5bsr9z","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"17:03:48","subject":"公告本公司114年股東常會同意解除董事競業禁止之限制案","clause":"第21款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：生展（8279），2025-05-28 17:03，「公告本公司114年股東常會同意解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-05-28-1703-1o5c8e4","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"17:03:02","subject":"代重要子公司Acepodia Biotech,Inc更新與Pfizer Inc.輝瑞之Pfizer Ignite計畫合作進度","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-05-28 17:03，「代重要子公司Acepodia Biotech,Inc更新與Pfizer Inc.輝瑞之Pfizer Ignite計畫合作」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-05-28-1702-1qnwcfe","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"17:02:11","subject":"本公司董事會決議113年第二次限制員工權利新股發行及訂定增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-05-28 17:02，「本公司董事會決議113年第二次限制員工權利新股發行及訂定增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-05-28-1701-17ygywa","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"17:01:35","subject":"公告本公司財務主管、會計主管、代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-05-28 17:01，「公告本公司財務主管、會計主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-05-28-1701-uutmnv","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"17:01:04","subject":"公告本公司稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-05-28 17:01，「公告本公司稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2025-05-28-1652-1ys2sou","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"16:52:04","subject":"公告本公司董事長決定配息基準日與發放日相關事宜","clause":"第14款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：生展（8279），2025-05-28 16:52，「公告本公司董事長決定配息基準日與發放日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-05-28-1651-ds864w","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"16:51:17","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-05-28 16:51，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-05-28-1641-j7pqx9","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"16:41:11","subject":"公告本公司眼藥水治療乾燥症病人眼角膜破損二期臨床實驗初步結果(補充5/19重訊次要療效評估指標內容)","clause":"第8款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-05-28 16:41，「公告本公司眼藥水治療乾燥症病人眼角膜破損二期臨床實驗初步結果(補充5/19重訊次要療效評估指標內容)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-05-28-1633-1s1tpxi","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"16:33:32","subject":"公告本公司第二屆永續發展委員會委員名單","clause":"第6款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-05-28 16:33，「公告本公司第二屆永續發展委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-05-28-1630-nkspxe","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"16:30:35","subject":"更正本公司114年04月關係人交易申報資訊","clause":"第53款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-05-28 16:30，「更正本公司114年04月關係人交易申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-05-28-1628-1jaof8b","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"16:28:38","subject":"公告本公司113年股東常會重要決議事項","clause":"第18款","fact_date":"2024-05-28","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-05-28 16:28，「公告本公司113年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-05-28-1554-ya1oy7","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:54:07","subject":"公告本公司董事長訂定除息基準日相關事宜","clause":"第14款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-05-28 15:54，「公告本公司董事長訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-05-28-1534-33lsls","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:34:41","subject":"公告本公司薪酬委員會任期屆滿","clause":"第6款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-05-28 15:34，「公告本公司薪酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-05-28-1529-s0kpz3","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:29:50","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-05-28 15:29，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-05-28-1529-163yh6k","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"15:29:02","subject":"董事會決議申請庫藏股買回","clause":"第35款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-05-28 15:29，「董事會決議申請庫藏股買回」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-05-28-1528-13sk2v0","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:28:15","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-05-28 15:28，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-05-28-1527-exylr3","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:27:11","subject":"公告本公司股東常會通過解除本公司新任董事及其代表人競業行為之限制","clause":"第21款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-05-28 15:27，「公告本公司股東常會通過解除本公司新任董事及其代表人競業行為之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-05-28-1525-19m2jjq","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:25:52","subject":"公告本公司114年股東常會全面改選董事事宜","clause":"第6款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-05-28 15:25，「公告本公司114年股東常會全面改選董事事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-05-28-1524-ds864w","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:24:15","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-05-28 15:24，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-05-28-1523-y7k3iq","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"15:23:07","subject":"更正公告本公司興櫃前法人說明會地點。","clause":"第9款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-05-28 15:23，「更正公告本公司興櫃前法人說明會地點。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-28-1515-4yzujo","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:15:56","subject":"公告本公司訂定除息基準日相關事宜","clause":"第14款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-28 15:15，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-28-1515-ds864w","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"15:15:32","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-28 15:15，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-05-28-1504-1cugv11","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"15:04:47","subject":"公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-05-28 15:04，「公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-05-28-1504-ds864w","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"15:04:23","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-05-28 15:04，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-05-28-1436-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"14:36:54","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-05-28 14:36，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-05-28-1357-ds864w","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"13:57:34","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-05-28 13:57，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-05-28-1357-999jew","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"13:57:07","subject":"公告本公司114年股東常會決議通過解除董事競業限制案","clause":"第21款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-05-28 13:57，「公告本公司114年股東常會決議通過解除董事競業限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-05-28-1131-1ipy30","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"11:31:07","subject":"公告本公司董事會決議股利配發基準日","clause":"第14款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-05-28 11:31，「公告本公司董事會決議股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-05-28-1123-1asmasq","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-05-28","time":"11:23:49","subject":"本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-05-28 11:23，「本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-05-28-1118-1m17pam","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"11:18:59","subject":"公告本公司董事會選任董事長及副董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-05-28 11:18，「公告本公司董事會選任董事長及副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-05-28-1118-r8x24z","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"11:18:24","subject":"公告本公司審計委員會委員任期屆滿改選","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-05-28 11:18，「公告本公司審計委員會委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-05-28-1117-dnjb71","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"11:17:59","subject":"公告本公司第五屆薪酬委員任期屆滿","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-05-28 11:17，「公告本公司第五屆薪酬委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-05-28-1117-95t2yh","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"11:17:36","subject":"公告本公司2025年股東常會通過解除新任董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-05-28 11:17，「公告本公司2025年股東常會通過解除新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-05-28-1117-1rrtfpz","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"11:17:15","subject":"公告本公司2025年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-05-28 11:17，「公告本公司2025年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-05-28-1116-cc5145","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-05-28","time":"11:16:11","subject":"公告本公司2025年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-05-28 11:16，「公告本公司2025年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-05-28-1110-9xh4g5","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-05-28","time":"11:10:05","subject":"公告本公司受邀參加中國信託證券股份有限公司舉辦之興櫃前法人說明會。","clause":"第9款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-05-28 11:10，「公告本公司受邀參加中國信託證券股份有限公司舉辦之興櫃前法人說明會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}